"Opavsk\u00FD, Jaroslav" . "The guidelines were developed by a Task Force of the Czech Neurological Society and The Czech Pain Society. The major recommendations were adapted from the key international guidelines: The EFNS guidelines by Attal et al [6] and The guidelines of the Neuropathic Pain Special Interest Group - part of the The International Association for the Study of Pain by Dworkin et al [7]. Level of evidence of all recommendations was classified according to the EFNS classification by Brainin et al [10]. Recommendations were stratified as a treatment of the first, second and third lines, separately for painful polyneuropathies including diabetic polyneuropathy, trigeminal neuralgia, postherpetic neuralgia and other localised peripheral neuropathic pain, central pain, cancer neuropathic pain, HIV neuropathy, neuropathic pain with comorbidities, and recommended combinations of drugs. In addition, the entire process of pharmacological treatment has been defined, including the diagnosis of neuropathic pain, classification, characteristics and mechanisms of action of the drugs used for pharmacotherapy of neuropathic pain."@en . "Rokyta, Richard" . "Klinick\u00FD standard byl vyvinut pracovn\u00ED skupinou \u010Cesk\u00E9 neurologick\u00E9 spole\u010Dnosti a Spole\u010Dnosti pro studium a l\u00E9\u010Dbu bolesti. Hlavn\u00ED doporu\u010Den\u00ED byla adaptov\u00E1na z kl\u00ED\u010Dov\u00FDch mezin\u00E1rodn\u00EDch doporu\u010Den\u00ED, vytvo\u0159en\u00FDch EFNS [6] a the Neuropathic Pain Special Interest Group - sou\u010D\u00E1sti The International Association for the Study of Pain [7]. S\u00EDla pr\u016Fkazu jednotliv\u00FDch doporu\u010Den\u00ED byla klasifikov\u00E1na podle syst\u00E9mu EFNS [10]. Doporu\u010Den\u00ED byla hierarchicky uspo\u0159\u00E1d\u00E1na jako doporu\u010Den\u00E1 l\u00E9\u010Dba 1., 2. a 3. volby, a to odd\u011Blen\u011B pro bolestiv\u00E9 polyneuropatie v\u010Detn\u011B diabetick\u00E9 polyneuropatie, neuralgii trigeminu, postherpetickou neuralgii a dal\u0161\u00ED lokalizovan\u00E9 perifern\u00ED neuropatick\u00E9 bolesti, centr\u00E1ln\u00ED neuropatickou bolest, n\u00E1dorovou neuropatickou bolest, neuropatickou bolest asociovanou s HIV neuropati\u00ED, s komorbiditami, a jsou uvedeny vhodn\u00E9 kombinace l\u00E9k\u016F. Klinick\u00FD standard obsahuje rovn\u011B\u017E definici cel\u00E9ho procesu farmakoterapie neuropatick\u00E9 bolesti v\u010Detn\u011B diagnostiky neuropatick\u00E9 bolesti, klasifikace, charakteristik a mechanizm\u016F \u00FA\u010Dink\u016F l\u00E9k\u016F doporu\u010Dovan\u00FDch pro farmakoterapii neuropatick\u00E9 bolesti."@cs . "Klinick\u00FD standard pro farmakoterapii neuropatick\u00E9 bolesti"@cs . . . "P\u00E1t\u00E1, M." . . . "144776" . "1" . "1"^^ . . "1210-7859" . "Ambler, Zdenek" . "\u010Cesk\u00E1 a slovensk\u00E1 neurologie a neurochirurgie" . . "postherpetic neuralgia; trigeminal neuralgia; painful polyneuropathy; pharmacotherapy; neuropathic pain"@en . "11"^^ . . . "15510" . . "Lej\u010Dko, Jan" . "Guidelines for Pharmacotherapy of Neuropathic Pain"@en . "I, P(NS9667)" . . "Such\u00FD, M." . "Koz\u00E1k, Jan" . "RIV/61989592:15510/12:33138895" . "75" . "Keller, Otakar" . "Ko\u017Een\u00FD, P." . "Klinick\u00FD standard pro farmakoterapii neuropatick\u00E9 bolesti" . "Guidelines for Pharmacotherapy of Neuropathic Pain"@en . "[391616F72FAC]" . . "RIV/61989592:15510/12:33138895!RIV13-MSM-15510___" . . . . . "CZ - \u010Cesk\u00E1 republika" . "9"^^ . "Mazanec, Radim" . "Klinick\u00FD standard pro farmakoterapii neuropatick\u00E9 bolesti"@cs . "Klinick\u00FD standard pro farmakoterapii neuropatick\u00E9 bolesti" . "Klinick\u00FD standard byl vyvinut pracovn\u00ED skupinou \u010Cesk\u00E9 neurologick\u00E9 spole\u010Dnosti a Spole\u010Dnosti pro studium a l\u00E9\u010Dbu bolesti. Hlavn\u00ED doporu\u010Den\u00ED byla adaptov\u00E1na z kl\u00ED\u010Dov\u00FDch mezin\u00E1rodn\u00EDch doporu\u010Den\u00ED, vytvo\u0159en\u00FDch EFNS [6] a the Neuropathic Pain Special Interest Group - sou\u010D\u00E1sti The International Association for the Study of Pain [7]. S\u00EDla pr\u016Fkazu jednotliv\u00FDch doporu\u010Den\u00ED byla klasifikov\u00E1na podle syst\u00E9mu EFNS [10]. Doporu\u010Den\u00ED byla hierarchicky uspo\u0159\u00E1d\u00E1na jako doporu\u010Den\u00E1 l\u00E9\u010Dba 1., 2. a 3. volby, a to odd\u011Blen\u011B pro bolestiv\u00E9 polyneuropatie v\u010Detn\u011B diabetick\u00E9 polyneuropatie, neuralgii trigeminu, postherpetickou neuralgii a dal\u0161\u00ED lokalizovan\u00E9 perifern\u00ED neuropatick\u00E9 bolesti, centr\u00E1ln\u00ED neuropatickou bolest, n\u00E1dorovou neuropatickou bolest, neuropatickou bolest asociovanou s HIV neuropati\u00ED, s komorbiditami, a jsou uvedeny vhodn\u00E9 kombinace l\u00E9k\u016F. Klinick\u00FD standard obsahuje rovn\u011B\u017E definici cel\u00E9ho procesu farmakoterapie neuropatick\u00E9 bolesti v\u010Detn\u011B diagnostiky neuropatick\u00E9 bolesti, klasifikace, charakteristik a mechanizm\u016F \u00FA\u010Dink\u016F l\u00E9k\u016F doporu\u010Dovan\u00FDch pro farmakoterapii neuropatick\u00E9 bolesti." . . . "000301028500015" . "Bedna\u0159\u00EDk, Josef" . . .